|
1
|
Sangiovanni A, Del Ninno E, Fasani P, et
al: Increased survival of cirrhotic patients with a hepatocellular
carcinoma detected during surveillance. Gastroenterology.
126:1005–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han Z: Recent progress in genomic
[corrected] research of liver cancer. Sci China C Life Sci.
52:24–30. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment, and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Neuveut C, Wei Y and Buendia MA:
Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol.
52:594–604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ng SA and Lee C: Hepatitis B virus X gene
and hepatocarcinogenesis. J Gastroenterol. 46:974–990. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brenneck J, Hipfner DR, Stark A, et al:
bantam encodes a developmentally regulated microRNA that controls
cell proliferation and regulates the proapoptotic gene hid in
Drosophila. Cell. 113:25–36. 2003. View Article : Google Scholar
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi XB, Tepper CG and deVere White RW:
Cancerous miRNAs and their regulation. Cell Cycle. 7:1529–1538.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Santhekadur PK, Das SK, Gredler R, et al:
Multifunction protein staphylococcal nuclease domain containing 1
(SND1) promotes tumor angiogenesis in human hepatocellular
carcinoma through novel pathway that involves nuclear factor κB and
miR-221. J Biol Chem. 287:13952–13958. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JK, Koqure T, Nuovo GJ, et al:
miR-221 silencing blocks hepatocellular carcinoma and promotes
survival. Cancer Res. 71:7608–7616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ogawa T, Enomoto M, Fujii H, et al:
MicroRNA-221/222 upregulation indicates the activation of stellate
cells and the progression of liver fibrosis. Gut. 61:1600–1609.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naugler WE, Sakurai T, Kim S, et al:
Gender disparity in liver cancer due to sex differences in
MyD88-dependent IL-6 production. Science. 317:121–124. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao JJ, Lin J, Yang H, et al:
MicroRNA-221/222 negatively regulates estrogen receptor α and is
associated with tamoxifen resistance in breast cancer. J Biol Chem.
283:31079–31086. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Acs G, Sells MA, Purcell RH, et al:
Hepatitis B virus produced by transfected HepG2 cells causes
hepatitis in chimpanzees. Proc Natl Acad Sci USA. 84:4641–4644.
1987. View Article : Google Scholar
|
|
17
|
Sells MA, Chen ML and Acs G: Production of
hepatitis B virus particles in HepG2 cells transfected with cloned
hepatitis B virus DNA. Proc Natl Acad Sci USA. 84:1005–1009. 1987.
View Article : Google Scholar
|
|
18
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: miR-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roderburq C, Urban GW, Bettermann K, et
al: Micro-RNA profiling reveals a role of miR-29 in human and
murine liver fibrosis. Hepatology. 53:209–218. 2011. View Article : Google Scholar
|
|
20
|
Pineau P, Volinia S, McJunkin K, et al:
miR-221 overexpression contributes to liver tumorigenesis. Proc
Natl Acad Sci USA. 107:264–269. 2010. View Article : Google Scholar :
|
|
21
|
Gramantieri L, Ferracin M, Formari F, et
al: Cyclin G1 is a target of miR-122a, a microRNA frequently
down-regulated in human hepatocellular carcinoma. Cancer Res.
67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
le Sage C, Nagel R, Egan DA, et al:
Regulation of the p27Kip1 tumor suppressor by miR-221
and miR-222 promotes cancer cell proliferation. EMBO J.
26:3699–3708. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Medina R, Zaidi SK, Liu CG, et al:
MicroRNAs 221 and 222 bypass quiescence and compromise cell
suvival. Cancer Res. 68:2773–2780. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rehman SK, Li SH, Wyszomierski SL, et al:
14-3-3ζ orchestrates mammary tumor onset and progression via
miR-221-mediated cell proliferation. Cancer Res. 74:363–373. 2014.
View Article : Google Scholar :
|
|
25
|
Su A, He S, Tian B, et al: MicroRNA-221
mediates the effects of PDGF-BB on migration, proliferation, and
the epithelial-mesenchymal transition in pancreatic cancer cells.
PLoS One. 8:e713092013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rommer A, Steinleitner K, Hackl H, et al:
Overexpression of primary microRNA 221/222 in acute myeloid
leukemia. BMC Cancer. 13:3642013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu MW, Chang HC, Chang SC, et al: Role of
reproductive factors in hepatocellular carcinoma: impact on
hepatitis B- and C-related risk. Hepatology. 38:1393–1400.
2003.PubMed/NCBI
|
|
28
|
Vesselinovitch SD, Itze L, Mihailovich N
and Rao KV: Modifying role of partial hepatectomy and gonadectomy
in ethylnitrosourea-induced hepatocarcinogenesis. Cancer Res.
40:1538–1542. 1980.PubMed/NCBI
|
|
29
|
Nakatani T, Roy G, Fujimoto N, et al: Sex
hormone dependency of diethylnitrosamine-induced liver tumors in
mice and chemoprevention by leuprorelin. Jpn J Cancer Res.
92:249–256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ng IO, Ng M and Fan ST: Better survival in
woman with respected hepatocellular carcinoma is not related to
tumor proliferation or expression of hormone receptors. Am J
Gastroenterol. 92:1355–1358. 1997.PubMed/NCBI
|
|
31
|
Jonas S, Bechstein WO, Heinze T, et al:
Female sex hormone receptor status in advanced hepatocellular
carcinoma and outcome after surgical resection. Surgery.
121:456–461. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nagasue N, Kohno H, Chang YC, et al:
Clinicopathologic comparisons between estrogen receptor-positive
and -negative hepatocellular carcinomas. Ann Surg. 212:150–154.
2009. View Article : Google Scholar
|
|
33
|
Liu WH, Yeh SH, Lu CC, et al: MicroRNA-18a
prevents estrogen receptor-α expression, promoting proliferation of
hepatocellular carcinoma cells. Gastroenterology. 136:683–693.
2009. View Article : Google Scholar
|
|
34
|
Shen L, Ahuja N, Shen Y, et al: DNA
methylation and environmental exposures in human hepatocellular
carcinoma. J Natl Cancer Inst. 94:755–761. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pike MC and Spicer DV: Hormonal
contraception and chemoprevention of female cancers. Endocr Relat
Cancer. 7:73–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dutertre M and Smith CL: Molecular
mechanisms of selective estrogen receptor modulator (SERM) action.
J Pharmacol Exp Ther. 295:431–437. 2000.PubMed/NCBI
|
